<DOC>
	<DOCNO>NCT00177580</DOCNO>
	<brief_summary>This study supplement patient ' current medication Pravastatin , cholesterol-lowering medication , try improve residual symptom schizophrenia , also improve cognitive functioning .</brief_summary>
	<brief_title>Improving Symptoms Schizophrenia Schizoaffective Disorder Supplementing Medications With Pravastatin</brief_title>
	<detailed_description>This study supplement patient ' current medication Pravastatin , cholesterol-lowering medication , try improve residual symptom also improve cognitive functioning . It consist 15 total study visit 28-week period time , one visit every 2 week . Blood draw do every 4 week throughout study monitor lipid level , C-Reactive protein , AST , ALT , CPK Total . Cognitive testing complete begin study end study . During study visit , staff monitoring vitals sign ( weight , height , blood pressure , pulse , waist/hip ratio ) , possible side effect , positive negative symptom , mood symptom , overall functioning .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<criteria>Diagnosis schizophrenia schizoaffective disorder Male female subject ; age 1865 year inclusive Ability provide inform consent No psychiatric hospitalization last 30 day prior randomization PANSS score study entry 80 120 inclusive , OR continue experience residual positive and/or negative symptom baseline level functioning . Current psychiatric medication stable least 30 day Currently receive one antipsychotic medication Female subject childbearing age must use acceptable method birth control Active , uncontrolled , chronic liver disease Heart failure Current alcohol abuse dependence Female subject pregnant , lactating plan become pregnant study period History allergic reaction statin past Kidney disorder evidence renal dysfunction Uncontrolled diabetes Untreated hyperlipidemia Concurrently receive treatment cyclosporine , gemfibrozil , clofibrate , fenofibrate , niacin , macrolide antibiotic , erythromycin , HIV protease inhibitor , nefazodone , verapamil</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>schizoaffective disorder</keyword>
	<keyword>positive symptom</keyword>
	<keyword>negative symptom</keyword>
	<keyword>cognitive functioning</keyword>
	<keyword>pravastatin</keyword>
</DOC>